MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02807cam a2200481 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ocn840583196 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20221129121746.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr ||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
110927s2012 nyua ob 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2019723700 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
9781621009665 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781621009177 |
| Qualifying information |
hardcover |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
1621009661 |
| Qualifying information |
(electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
1621009173 |
| Qualifying information |
(hardcover) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
571594 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)840583196 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
WD 200.5.H8 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
027000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
060000 |
| Source |
bisacsh |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Dyslipidemia : |
| Subtitle |
causes, diagnosis, and treatment |
| Medium |
[E-Book] |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New York : |
| Name of producer, publisher, distributor, manufacturer |
Nova Science Publishers, Incorporated, |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2012] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Physical description |
1 online resource. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 490 1# - SERIES TITLE |
|---|
| Series statement |
Endocrinology research and clinical developments |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - CONTENTS |
|---|
| Contents |
Diet and nutrition therapy in dyslipidemia management / Rakesh Sharma, Robert J. Moffatt -- HDL heterogeneity and function : implications for therapeutics / Shih Ling Kao, Ying Jie Chee, Sue-Anne Toh -- Dyslipidemia : causes, diagnosis and treatment / Athanasia K. Papazafiropoulou, Marina S. Kardara, Stavros I. Pappas -- Fish proteins for coronary artery disease / Rakesh Sharma, Jose Katz -- Qualitative and quantitative characteristics of low-density lipoproteins in atherosclerosis-related diseases / Jelena Vekic [and others] -- The role of ligand-activated transcription factors PPAR, LXR, CAR, and PXR in the development of metabolic syndrome / Elena N. Pivovarova -- Endothelial lipase : its role in the metabolism of HDL-cholesterol, the relationship to cardiovascular risk and therapeutic opportunities / D. Agapakis [and others] -- The association between dyslipidemia and neuropathy / Mayowa Ojo Owolabi -- Fenofibrate-mediated anti-atherogenic activity : long-term follow-up study of rheumatoid arthritis patients by comparing with statin therapy / Makoto Goto. |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
Master record variable field(s) change: 050, 082 |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Lipids |
| General subdivision |
Metabolism |
| -- |
Disorders. |
| 650 12 - SUBJECT HEADINGS |
|---|
| Subject term |
Dyslipidemias. |
| 650 22 - SUBJECT HEADINGS |
|---|
| Subject term |
Lipoproteins, HDL |
| General subdivision |
physiology. |
| 700 1# - ADDED PERSONAL NAME |
|---|
| Added personal author |
Karapetrovic, Miroslava. |
| 700 1# - ADDED PERSONAL NAME |
|---|
| Added personal author |
Acimovic, Zlatko. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Endocrinology research and clinical developments. |
| 856 40 - ONLINE RESOURCE |
|---|
| Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=571594">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=571594</a> |
| Link text |
Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Suppress in OPAC |
Do not Suppress in OPAC |
| 588 ## - SOURCE OF DESCRIPTION NOTE |
|---|
| Source of description note |
Description based on print version record. |